As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 4/16/24  Soleus Private Equity Fd I, L.P.  SC 13D/A               1:171K BioAtla, Inc.                     EdgarAgents LLC/FA       
          Guy Levy³
          Soleus Capital Group, LLC³
          Soleus Capital Master Fund, L.P.³
          Soleus Capital, LLC³
          Soleus Pe GP I, LLC³
          Soleus Private Equity GP I, LLC³
  2/9/24  Soleus Capital Master Fund, L.P.  SC 13G/A               1:228K Celcuity Inc.                     EdgarAgents LLC/FA       
          Guy Levy³
          Soleus Capital Group, LLC³
          Soleus Capital, LLC³
          Soleus Pe GP II, LLC³
          Soleus Private Equity Fund II, L.P.³
          Soleus Private Equity GP II, LLC³
  2/8/24  Soleus Capital Master Fund, L.P.  SC 13G/A               1:162K CalciMedica, Inc.                 EdgarAgents LLC/FA       
          Guy Levy³
          Soleus Capital Group, LLC³
          Soleus Capital, LLC³
          Soleus Pe GP III, LLC³
          Soleus Private Equity Fund III, L.P.³
          Soleus Private Equity GP III, LLC³
  2/6/24  Soleus Private Equity Fd III, LP  SC 13G/A               1:151K Harpoon Therapeutics, Inc.        EdgarAgents LLC/FA       
          Guy Levy³
          Soleus Capital Group, LLC³
          Soleus Capital Master Fund, L.P.³
          Soleus Capital, LLC³
          Soleus Pe GP III, LLC³
          Soleus Private Equity GP III, LLC³
  2/6/24  Soleus Private Equity Fd III, LP  SC 13G/A               1:155K Mereo BioPharma Group plc         EdgarAgents LLC/FA       
          Guy Levy³
          Soleus Capital Group, LLC³
          Soleus Capital Master Fund, L.P.³
          Soleus Capital, LLC³
          Soleus Pe GP III, LLC³
          Soleus Private Equity GP III, LLC³
  2/5/24  Soleus Capital Master Fund, L.P.  SC 13G                 1:106K C4 Therapeutics, Inc.             EdgarAgents LLC/FA       
          Guy Levy³
          Soleus Capital Group, LLC³
          Soleus Capital, LLC³
  2/2/24  Soleus Capital Master Fund, L.P.  SC 13G/A               1:101K Pieris Pharmaceuticals, Inc.      EdgarAgents LLC/FA       
          Guy Levy³
          Soleus Capital Group, LLC³
          Soleus Capital, LLC³
  2/2/24  Soleus Capital Master Fund, L.P.  SC 13G/A               1:106K Rigel Pharmaceuticals Inc.        EdgarAgents LLC/FA       
          Guy Levy³
          Soleus Capital Group, LLC³
          Soleus Capital, LLC³
  2/2/24  Soleus Capital Master Fund, L.P.  SC 13G/A               1:97K  Organogenesis Holdings Inc.       EdgarAgents LLC/FA       
          Guy Levy³
          Soleus Capital Group, LLC³
          Soleus Capital, LLC³
  2/2/24  Soleus Capital Master Fund, L.P.  SC 13G/A               1:96K  Surmodics Inc.                    EdgarAgents LLC/FA       
          Guy Levy³
          Soleus Capital Group, LLC³
          Soleus Capital, LLC³
  2/2/24  Soleus Capital Master Fund, L.P.  SC 13G/A               1:141K Jasper Therapeutics, Inc.         EdgarAgents LLC/FA       
          Guy Levy³
          Soleus Capital Group, LLC³
          Soleus Capital, LLC³
  2/2/24  Soleus Capital Master Fund, L.P.  SC 13G/A               1:108K Verastem, Inc.                    EdgarAgents LLC/FA       
          Guy Levy³
          Soleus Capital Group, LLC³
          Soleus Capital, LLC³
  2/2/24  Soleus Capital Master Fund, L.P.  SC 13G/A               1:157K Iradimed Corp.                    EdgarAgents LLC/FA       
          Guy Levy³
          Soleus Capital Group, LLC³
          Soleus Capital, LLC³
  2/2/24  Soleus Capital Master Fund, L.P.  SC 13G/A               1:136K VYNE Therapeutics Inc.            EdgarAgents LLC/FA       
          Guy Levy³
          Soleus Capital Group, LLC³
          Soleus Capital, LLC³
  2/2/24  Soleus Capital Master Fund, L.P.  SC 13G/A               1:150K Edap TMS SA                       EdgarAgents LLC/FA       
          Guy Levy³
          Soleus Capital Group, LLC³
          Soleus Capital, LLC³
          Soleus Pe GP III, LLC³
          Soleus Private Equity Fund III, L.P.³
          Soleus Private Equity GP III, LLC³
  2/2/24  Soleus Capital Master Fund, L.P.  SC 13G/A               1:94K  Delcath Systems, Inc.             EdgarAgents LLC/FA       
          Guy Levy³
          Soleus Capital Group, LLC³
          Soleus Capital, LLC³
  2/2/24  Soleus Capital Master Fund, L.P.  SC 13G/A               1:94K  C4 Therapeutics, Inc.             EdgarAgents LLC/FA       
          Guy Levy³
          Soleus Capital Group, LLC³
          Soleus Capital, LLC³
  2/2/24  Soleus Capital Master Fund, L.P.  SC 13G/A               1:110K Axogen, Inc.                      EdgarAgents LLC/FA       
          Guy Levy³
          Soleus Capital Group, LLC³
          Soleus Capital, LLC³
  2/2/24  Soleus Private Equity Fd I, L.P.  SC 13G/A               1:157K NeuroPace Inc.                    EdgarAgents LLC/FA       
          Guy Levy³
          Soleus Capital Group, LLC³
          Soleus Capital Master Fund, L.P.³
          Soleus Capital, LLC³
          Soleus Pe GP I, LLC³
          Soleus Private Equity GP I, LLC³
 1/26/24  Soleus Capital Master Fund, L.P.  SC 13G                 1:106K CalciMedica, Inc.                 EdgarAgents LLC/FA       
          Guy Levy³
          Soleus Capital Group, LLC³
          Soleus Capital, LLC³

____________
¹	Filing/Form Types:
	SC 13D	Statement of Acquisition of Beneficial Ownership by an “Active” Investor — Schedule 13D.
	SC 13G	Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.
³	Group Member:  A Registrant or non-Registrant party to this Filing made by a Group.